Effects of hyperglycemia on glucose metabolism before and after oral glucose ingestion in normal men

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 6, 2006, Pages

  Rigalleau, Vincent ^a   Beauvieux, Marie Christine ^a   Gallis, Jean Louis ^a   Gin, Henri ^a   Schneiter, Phillippe ^b   Tappy, Luc ^b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Endogenous glucose production; Glucose cycle; Glucose disposal rate; Glucose tolerance

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLING; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; HYPERGLYCEMIA; MALE; PRIORITY JOURNAL; SYSTEMIC CIRCULATION;

ADMINISTRATION, ORAL; BLOOD GLUCOSE; C-PEPTIDE; GLUCAGON; GLUCOSE; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; MIDDLE AGED; TIME FACTORS;

EID: 33744940245     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00407.2005     Document Type: Article

References (44)

1. Alzaid AA, Dinneen SF, Turk DJ, Caumo A, Cobelli C, and Rizza RA. Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans. J Clin Invest 94: 2341-2348, 1994.
2. Baron AD, Brechtel G, Wallace P, and Edelman SV. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol Endocrinol Metab 255: E769-E774, 1988.
3. Bell PM, Firth RG, and Rizza RA. Assessment of the postprandial pattern of glucose metabolism in nondiabetic subjects and patients with non-insulin-dependent diabetes mellitus using a simultaneous infusion of [2(3)H] and [3(3)H] glucose. Metabolism 38: 38-45, 1989.
4. Bell PM, Firth RG, and Rizza RA. Effects of hyperglycaemia on glucose production and utilization in humans. Measurement with [23H]-, [33H]-, and [614C]glucose. Diabetes 35: 642-648, 1986.
5. Bell PM, Firth RG, and Rizza RA. The effects of hyperglycaemia on isotopic measurement of glucose utilization using [23H], [33H], and [614C] glucose in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 365-371, 1987.
6. Butler PC and Rizza RA. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose intolerant or NDDM patients. Diabetes 40: 73-81, 1991.
7. DeFronzo RA, Ferrannini E, Hendler R, Felig P, and Wahren J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 32: 35-45, 1983.
8. DeFronzo RA, Tobin JD, and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E214-E223, 1979.
9. Dinneen S, Alzaid A, Turk D, and Rizza RA. Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Diabetologia 38: 337-343, 1995.
10. Efendic S, Karlander S, and Vranic M. Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity. J Clin Invest 81: 1953-1961, 1988.
11. Felley CP, Felley EM, Van Melle GD, Frascarolo P, Jéquier E, and Felber JP. Impairment of glucose disposal by infusion of triglycerides in humans: role of glycemia. Am J Physiol Endocrinol Metab 256: E747-E752, 1989.
12. Ferrannini E. The theoretical basis of indirect calorimetry: a review. Metabolism 37: 287-301, 1988.
13. Ferrannini E, Locatelli L, Jéquier E, and Felber JP. Differential effects of insulin and hyperglycemia on intracellular glucose disposition in humans. Metabolism 38: 459-465, 1989.
14. Fery F, d'Atellis NP, and Balasse EO. Mechanisms of starvation diabetes: a study with double tracer and indirect calorimetry. Am J Physiol Endocrinol Metab 259: E770-E777, 1990.
15. Féry F, Devière J, and Balasse EO. Metabolic handling of intraduodenal vs. intravenous glucose in humans. Am J Physiol Endocrinol Metab 281: E261-E268, 2001.
16. Fery F, Tappy L, Schneiter P, Deviere J, and Balasse EO. Effect of somatostatin on duodenal glucose absorption in man. J Clin Endocrinol Metab 90: 4163-4169, 2005.
17. Finegood DT, Bergman RM, and Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabelled and labelled glucose infusates. Diabetes 36: 914-924, 1987.
18. Forbes A, Elliott T, Tildesley H, Finegood D, and Meneilly GS. Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes. Diabetes 47: 1915-1919, 1998.
19. Guignot L and Mithieux G. Mechanisms by which insulin, associated or not with glucose, may inhibit hepatic glucose production in the rat. Am J Physiol Endocrinol Metab 277: E984-E989, 1999.
20. Hellerstein MK, Neese RA, Schwarz JM, Turner S, Faix D, and Wu K. Altered fluxes responsible for reduced hepatic glucose production and gluconeogenesis in rats. Am J Physiol Endocrinol Metab 272: E163-E172, 1997.
21. Henry RR, Gumbiner B, Flynn T, and Thorburn AW. Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM. Diabetes 39: 149-156, 1990.
22. Hother-Nielsen O, Henriksen JE, Holst JJ, and Beck-Nielsen H. Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique. Metabolism 45: 82-91, 1996.
23. Hother-Nielsen O, Vaag A, Skott P, and Beck-Nielsen H. Effect of hyperglycemia per se on glucose turnover rates in patients with insulin-dependent diabetes. Metabolism 42: 86-93, 1993.
24. Karlander S, Roovete A, Vranic M, and Efendic S. Glucose and fructose 6-phosphate cycle in humans. Am J Physiol Endocrinol Metab 251: E530-E536, 1986.
25. Kelley D, Mitrakou A, Marsh H, Schwenk F, Benn J, Sonnenberg G, Arcangeli M, Aoki T, Sorensen J, Berger M, Sonksen P, and Gerich J. Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest 81: 1563-1571, 1988.
26. Livesey G, Wilson PD, Roe MA, Faulks RM, Oram LM, Brown JC, Eagles J, Greenwood RH, and Kennedy H. Splanchnic retention of intraduodenal and intrajejunal glucose in healthy adults. Am J Physiol Endocrinol Metab 275: E709-E716, 1998.
27. Ludvik B, Nolan JJ, Roberts A, Baloga J, Joyce M, Bell JM, and Olefsky JM. A noninvasive method to measure splanchnic glucose uptake after oral glucose administration. J Clin Invest 95: 2232-2238, 1995.
28. Mandarino LJ, Consoli A, Jain A, and Kelley DE. Differential regulation of intracellular glucose metabolism by glucose and insulin in human muscle. Am J Physiol Endocrinol Metab 265: E898-E905, 1993.
29. Mevorach M, Giacca A, Aharon Y, Hawkins M, Shamoon H, and Rossetti L. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest 102: 744-753, 1998.
30. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, and Gerich J. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326: 22-29, 1992.
31. Miyoshi H, Shulman GI, Peters EJ, Wolfe MH, Elahi D, and Wolfe RR. Hormonal control of substrate cycling in humans. J Clin Invest 81: 1545-1555, 1988.
32. Moore MC, Satake S, Baranowski B, Hsieh PS, Neal DW, and Cherrington AD. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Am J Physiol Endocrinol Metab 282: E286-E296, 2002.
33. Proietto J, Rohner-Jeanrenaud F, Ionescu E, Terretaz J, Sauter JF, and Jeanrenaud B. Non-steady-state measurement of glucose turnover in rats by using a one-compartment model. Am J Physiol Endocrinol Metab 252: E77-E84, 1987.
34. Radziuk J. Hepatic glycogen in humans. II. Gluconeogenetic formation after oral and intravenous glucose. Am J Physiol Endocrinol Metab 257: E158-E169, 1989.
35. Rigalleau V, Beylot M, Pacciaudi C, Guillot C, Deleris G, and Gin H. Mechanisms of glucose intolerance during triglyceride infusion. Am J Physiol Endocrinol Metab 275: E641-E648, 1998.
36. Rigalleau V, Binnert C, Minehira K, Stefanoni N, Schneiter P, Henchoz E, Matzinger O, Cayeux C, Jéquier E, and Tappy L. In normal men, free fatty acids reduce peripheral, but not splanchnic glucose uptake. Diabetes 50: 727-32, 2001.
37. Rognstad R. Glucose-6-phosphatase flux and the hepatic glucose balance model. Am J Physiol Endocrinol Metab 271: E1125-E1127, 1996.
38. Rossetti L, Giaccari A, Barzilai N, Howard K, Sebel G, and Hu M. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. J Clin Invest 92: 1126-1134, 1993.
39. Soop M, Nygren J, Brismar K, Thorell A, and Ljungqvist O. The hyperinsulinaemic-euglycaemic glucose clamp: reproducibility and metabolic effects of prolonged insulin infusion in healthy subjects. Clin Sci (Lond) 98: 367-374, 2000.
40. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82: 420-430, 1959.
41. Tappy L, Berger M, Schwarz JM, McCamish M, Revelly JP, Schneiter P, Jequier E, and Chiolero R. Hepatic and peripheral glucose metabolism in intensive care patients receiving continuous high- or low-carbohydrate enteral nutrition. J Parenter Enteral Nutr 23: 260-268, 1999.
42. Tappy L, Dussoix P, Lynedjian P, Henry S, Schneiter P, Zhand G, Jéquier E, and Philippe J. Abnormal regulation of hepatic glucose output in maturity-onset diabetes of the young caused by a specific mutation of the glucokinase gene. Diabetes 46: 204-208, 1997.
43. Verdonk CA, Rizza RA, and Gerich GE. Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man. Diabetes 30: 535-537, 1981.
44. Yki-Järvinen H. Review: acute and chronic effects of hyperglycaemia on glucose metabolism. Diabetologia 33: 579-585, 1990.